These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 30497375)
1. Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18. Molina D; Cossio-Pérez R; Rocha-Roa C; Pedraza L; Cortes E; Hernández A; Gómez-Marín JE BMC Genomics; 2018 Nov; 19(1):856. PubMed ID: 30497375 [TBL] [Abstract][Full Text] [Related]
2. A Perspective on Thiazolidinone Scaffold Development as a New Therapeutic Strategy for Toxoplasmosis. Rocha-Roa C; Molina D; Cardona N Front Cell Infect Microbiol; 2018; 8():360. PubMed ID: 30386743 [No Abstract] [Full Text] [Related]
3. Prediction of Toxoplasma gondii virulence factor ROP18 competitive inhibitors by virtual screening. Yin K; Zhao G; Xu C; Qiu X; Wen B; Sun H; Liu G; Liu Y; Zhao Q; Wei Q; Huang B; Yan G; Cao J Parasit Vectors; 2019 Mar; 12(1):98. PubMed ID: 30867024 [TBL] [Abstract][Full Text] [Related]
4. Association of ROP18 and ROP5 was efficient as a marker of virulence in atypical isolates of Toxoplasma gondii obtained from pigs and goats in Piauí, Brazil. Rêgo WMF; Costa JGL; Baraviera RCA; Pinto LV; Bessa GL; Lopes REN; Vitor RWA Vet Parasitol; 2017 Nov; 247():19-25. PubMed ID: 29080759 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of anti-Toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives. Carradori S; Secci D; Bizzarri B; Chimenti P; De Monte C; Guglielmi P; Campestre C; Rivanera D; Bordón C; Jones-Brando L J Enzyme Inhib Med Chem; 2017 Dec; 32(1):746-758. PubMed ID: 28537532 [TBL] [Abstract][Full Text] [Related]
6. Interactions between the ROP18 kinase and host cell proteins that aid in the parasitism of Toxoplasma gondii. Cheng L; Chen Y; Chen L; Shen Y; Shen J; An R; Luo Q; Du J Acta Trop; 2012 Jun; 122(3):255-60. PubMed ID: 22365922 [TBL] [Abstract][Full Text] [Related]
7. Encephalitis is mediated by ROP18 of An R; Tang Y; Chen L; Cai H; Lai DH; Liu K; Wan L; Gong L; Yu L; Luo Q; Shen J; Lun ZR; Ayala FJ; Du J Proc Natl Acad Sci U S A; 2018 Jun; 115(23):E5344-E5352. PubMed ID: 29784816 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of novel arctigenin derivatives as potential anti-Toxoplasma gondii agents. Zhang HB; Shen QK; Wang H; Jin C; Jin CM; Quan ZS Eur J Med Chem; 2018 Oct; 158():414-427. PubMed ID: 30237124 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of ATF6β-dependent host adaptive immune response by a Toxoplasma virulence factor ROP18. Yamamoto M; Takeda K Virulence; 2012; 3(1):77-80. PubMed ID: 22286708 [TBL] [Abstract][Full Text] [Related]
10. Virus-Like Particles Expressing Toxoplasma gondii Rhoptry Protein 18 Induces Better Protection Than Rhoptry Protein 4 against T. gondii Infection. Kang HJ; Lee SH; Chu KB; Lee DH; Quan FS Korean J Parasitol; 2018 Oct; 56(5):429-435. PubMed ID: 30419728 [TBL] [Abstract][Full Text] [Related]
11. The ROP18 and ROP5 gene allele types are highly predictive of virulence in mice across globally distributed strains of Toxoplasma gondii. Shwab EK; Jiang T; Pena HF; Gennari SM; Dubey JP; Su C Int J Parasitol; 2016 Feb; 46(2):141-6. PubMed ID: 26699401 [TBL] [Abstract][Full Text] [Related]
12. Structure of the Toxoplasma gondii ROP18 kinase domain reveals a second ligand binding pocket required for acute virulence. Lim D; Gold DA; Julien L; Rosowski EE; Niedelman W; Yaffe MB; Saeij JP J Biol Chem; 2013 Nov; 288(48):34968-80. PubMed ID: 24129568 [TBL] [Abstract][Full Text] [Related]
13. Proteasomal degradation of T. gondii ROP18 requires Derlin2. Tang Y; Zheng M; An R; Chen L; Gong L; Cai H; Liu K; Yu L; Shen J; Du J Acta Trop; 2017 Oct; 174():106-113. PubMed ID: 28669563 [TBL] [Abstract][Full Text] [Related]
14. [Construction and Identification of Transgenic Strain of Toxoplasma gondii High-expressing Virulence Factor ROP18]. Jiang ZR; An R; Yang J; Wan LJ; Du J Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2015 Feb; 33(1):14-8. PubMed ID: 26080519 [TBL] [Abstract][Full Text] [Related]
15. Novel structural and regulatory features of rhoptry secretory kinases in Toxoplasma gondii. Qiu W; Wernimont A; Tang K; Taylor S; Lunin V; Schapira M; Fentress S; Hui R; Sibley LD EMBO J; 2009 Apr; 28(7):969-79. PubMed ID: 19197235 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the virulence determination mechanisms in a local Toxoplasma strain (T.gHB1) isolated from central China. Zhang W; Li L; Xia N; Zhou Y; Fang R; He L; Hu M; Shen B; Zhao J Parasitol Res; 2016 Oct; 115(10):3807-15. PubMed ID: 27225000 [TBL] [Abstract][Full Text] [Related]
17. Deciphering ophthalmic adaptive inhibitors targeting RON4 of Toxoplasma gondii: An integrative in silico approach. Vetrivel U; Nagarajan H Life Sci; 2018 Nov; 213():82-93. PubMed ID: 30326220 [TBL] [Abstract][Full Text] [Related]
18. T. gondii rhoptry protein ROP18 induces apoptosis of neural cells via endoplasmic reticulum stress pathway. Wan L; Gong L; Wang W; An R; Zheng M; Jiang Z; Tang Y; Zhang Y; Chen H; Yu L; Shen J; Du J Parasit Vectors; 2015 Oct; 8():554. PubMed ID: 26489755 [TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of new 4-thiazolidinones on invasion and growth of Toxoplasma gondii. Molina DA; Ramos GA; Zamora-Vélez A; Gallego-López GM; Rocha-Roa C; Gómez-Marin JE; Cortes E Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():129-139. PubMed ID: 34102589 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological characterization of thiazolidin-4-one derivatives as promising inhibitors of Toxoplasma gondii. D'Ascenzio M; Bizzarri B; De Monte C; Carradori S; Bolasco A; Secci D; Rivanera D; Faulhaber N; Bordón C; Jones-Brando L Eur J Med Chem; 2014 Oct; 86():17-30. PubMed ID: 25140751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]